Siegfried initiated with an Outperform at William Blair

William Blair initiated coverage of Siegfried (SGFEF) with an Outperform rating and no price target The company produces solid returns in drug manufacturing but trades at a significant discount to peers, the analyst tells investors in a research note. It believes the stock should be worth about CHF 100 at the end of the year, which represents 20% upside to current levels.